Randomised clinical trial: Symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention
Open accessAbstract
Background Evidence supports the effectiveness of cognitive behavioural approaches in improving the symptoms of the irritable bowel syndrome (IBS). Duration, cost and resistance of many patients towards a psychological therapy have limited their acceptance. Aim To evaluate the effectiveness of a psycho-educational intervention on IBS symptoms. Methods Sixty-nine IBS patients (72% female) were randomised to an intervention or a wait-list control group. The IBS class consisted of education on a biological mind body disease model emphasising self-efficacy and practical relaxation techniques. Results Patients in the intervention showed significant improvement on GI symptom severity, visceral sensitivity, depression and QoL postintervention and most of these gains were maintained at 3-month follow-up (Hedge's g = -0.46-0.77). Moderated mediation analyses indicated change in anxiety, visceral sensitivity, QoL and catastrophising due to the intervention had moderate mediation effects (Hedge's g = -0.38 to -0.60) on improvements in GI symptom severity for patients entering the trial with low to average QoL. Also, change in GI symptom severity due to the intervention had moderate mediation effects on improvements in QoL especially in patients with low to average levels of QoL at baseline. Moderated mediation analyses indicated mediation was less effective for patients entering the intervention with high QoL. Conclusions A brief psycho-educational group intervention is efficacious in changing cognitions and fears about the symptoms of the irritable bowel syndrome, and these changes are associated with clinically meaningful improvement in symptoms and quality of life. The intervention seems particularly tailored to patients with low to moderate quality of life baseline levels. © 2012 Blackwell Publishing Ltd.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
13 of 44 cited sources checked · 4 supported · 1 flagged · accuracy not yet measured
- Premisecitation
Research on short-term psycho-education programs that include cognitive therapy and stress management elements has yielded mixed outcomes.
“Research on short-term education programs that include some elements of cognitive therapy and stress management (psycho-education) have yielded mixed outcomes.”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [26] source
The Discussion (page unavailable) reports differing degrees of improvement across outcomes, but explicitly says that the available studies of IBS education “all ... point in the same direction” toward benefit. That contradicts the attributed conclusion that these programs yielded mixed outcomes. The paper does not separately assess a body of short-term psycho-education programs defined by cognitive-therapy and stress-management elements. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [27] source
- cites [30] source
- Premisecitation
Psychological treatments including hypnotherapy, mindfulness, CBT, behavior therapy, patient education, and internet-based CBT have been shown to alleviate IBS-related symptoms.
“psychological treatments such as hypnotherapy and mindfulness(19-22), patient focused cognitive behavior therapy (CBT)(23), behavior therapy (BT)(24, 25), patient education(26), and internet based CBT(27) have all shown effectiveness in alleviating IBS related symptoms.”
Quote in the paperSubstantial claim1 of 7 sources checked- cites [19]
- cites [20] source
- cites [21] source
The Background reports positive results for hypnosis and decreased IBS symptom severity after mindfulness training in one small, uncontrolled pilot study. It also says there were no well-controlled clinical trials of mindfulness specifically for IBS; this paper describes a proposed trial, not an efficacy result from that trial. The other treatments in the citing sentence have separate citations and are not assessed here. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [22] source
- cites [23] source
- cites [24] source
- cites [25] source
- Premisecitation
Little is known about which risk and protective factors matter for any particular therapy.
“More importantly the specific risk and protective factors associated with any specific therapy remain poorly delineated in the literature(34).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [34] source
- Premisecitation
For IBS, drug treatments other than those for constipation or diarrhea are still unsatisfactory, since few trials demonstrate benefit over placebo.
“Currently pharmacologic therapy of IBS beyond symptomatic treatment for constipation or diarrhea remains unsatisfactory, as few studies have demonstrated an effectiveness of available treatments over placebo effects(13-18).”
Quote in the paperSubstantial claim2 of 6 sources checked- cites [13] source
- cites [14] source
- cites [15] source
- cites [16] source
The Abstract and Summary describe modest gains over placebo, and the Antispasmodics section says high-quality efficacy studies are limited. But the paper also reports evidence of benefit for treatments beyond constipation and diarrhea, including antispasmodics for abdominal pain and psychotropic agents for overall symptoms and pain. It therefore supports the assessment that treatment remains limited, but not the broad implication that few studies show benefit over placebo. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [17] source
The Methods section says the meta-analysis assesses probiotics for preventing antibiotic-associated diarrhea and treating Clostridium difficile disease. Searches for IBS, pharmacologic treatment, and placebo comparisons found no passage addressing whether IBS drugs outperform placebo. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [18] source
- Interpretationown data
Like Morris et al. and Jarrett et al. CBT interventions, this study demonstrated improved self-management skills among IBS patients.
“Similar to both Morris et al. (2010)(48) and Jarrett et al. (2009)(46) CBT based interventions, we were also able to demonstrate improved self-management skills among IBS patients.”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [48] source
The Methods (Treatment Phase; page unavailable) describe teaching IBS patients diet, relaxation, and cognitive-behavioral self-management strategies. The Results (Primary and Secondary Outcomes; page unavailable) report improved symptoms, quality of life, and cognitive beliefs, but do not establish that patients’ self-management skills improved. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [46] source
- Interpretationcitation
The study results are similar to landmark studies using CBT to improve IBS symptoms and quality of life.
“The results from our study are similar to landmark studies published in the field, on utilizing cognitive behavior therapy (CBT) to improve IBS symptoms and improve quality of life(33, 46, 48).”
Quote in the paperNot a substantial claim1 of 3 sources checked - Findingown data
The higher QoL in the intervention group compared with controls was maintained at 3-month follow-up (77.6 vs. 70.2; p = .012; g = .62).
“and at the 3-month follow-up (77.6 vs. 70.2, p=.012, g=.62).”
Quote in the paperSubstantial claim - Findingown data
At the end of the intervention, patients receiving psycho-education had lower depression scores than controls (4.6 vs. 6.5; p = 0.005; g = -.68).
“Patients receiving the intervention demonstrated lower depression scores at the end of the intervention compared to the controls (4.6 vs. 6.5, p = 0.005, g=−.68)”
Quote in the paperSubstantial claim - Findingown data
After adjusting for baseline affect, the intervention significantly reduced depression (p = 0.006).
“After adjusting for baseline levels of affect (p’s <.0001), the intervention reduced depression (p = 0.006) but not anxiety (p = 0.13).”
Quote in the paperNot a substantial claim - Findingown data
The psycho-education intervention had no effect on symptom severity among patients with high baseline IBS-QoL.
“Interestingly, the psycho-education intervention had no effects on symptom severity among patients with high baseline levels of IBS-QoL.”
Quote in the paperSubstantial claim - Findingown data
The improvement in catastrophizing in the intervention group compared with controls was maintained at follow-up (5.9 vs. 8.9; p = 0.012; g = -.62).
“and this difference was maintained at follow-up (5.9 vs. 8.9, p = 0.012, g=−.62).”
Quote in the paperSubstantial claim - Findingown data
The distribution of baseline overall symptom severity did not differ significantly between the intervention and control groups.
“without any significant differences between the intervention group (mild 14.7%, moderate 35.3%, severe 44.1%, very severe 5.9%) and the control group (mild 5.9%, moderate17.6%, severe 64.7%, very severe 11.8%).”
Quote in the paperSubstantial claim - Findingown data
Mediation effects were weaker for patients who entered the trial with high quality of life.
“Moderated mediation analyses indicated mediation was less effective for patients entering the intervention with high QoL.”
Quote in the paperSubstantial claim- Rests on an assumption: The mediation models' assumptions (no unmeasured confounding, correct temporal ordering, no reverse causality) hold, so that the estimated mediation effects reflect causal pathways.
- Findingreasoning
Group differences in visceral sensitivity were not maintained at 3-month follow-up (37.4 vs. 32.7; p = 0.06; g = -.42).
“Even though patients receiving the intervention maintained decreased visceral sensitivity at the 3-month follow-up assessment, group differences were not maintained (37.4 vs. 32.7, p = 0.06, g=−.42) due to a significant reduction in visceral sensitivity in the control group.”
Quote in the paperNot a substantial claim - Findingown data
The improvement in coping skills to control symptoms in the intervention group compared with controls was maintained at 3-month follow-up (3.2 vs. 2.5; p = 0.02; g = .56).
“and this improvement was maintained at 3-month follow-up (3.2 vs. 2.5, p = 0.02, g=.56).”
Quote in the paperSubstantial claim - Findingown data
The difference in coping skills to change or decrease symptoms was no longer significant at 3-month follow-up (2.6 vs. 2.3; p = 0.14; g = .36).
“but this difference was no longer significant at the 3-month follow-up assessment (2.6 vs. 2.3, p = 0.14, g=.36).”
Quote in the paperNot a substantial claim - Findingown data
The main effect of time on VSI was significant (p = .01).
“After controlling for baseline visceral sensitivity (p < 0.0001), the main effect of the psycho-education intervention on visceral sensitivity (VSI) levels was significant (p = 0.003) as was the main effect of time (p=.01).”
Quote in the paperNot a substantial claim - Findingown data
At the end of the intervention, patients receiving psycho-education had lower visceral sensitivity than controls (34.0 vs. 42.3; p = 0.001; g = -.84).
“Patients receiving the intervention demonstrated significantly less visceral sensitivity than controls at end of the class (34.0 vs. 42.3, p = 0.001, g=−.84).”
Quote in the paperSubstantial claim - Findingown data
The main effect of time on total IBS-QoL was significant (p = .04).
“The main effect for time was significant (p=.04).”
Quote in the paperNot a substantial claim - Findingown data
At the end of the intervention, patients receiving psycho-education had lower overall symptom severity than controls (7.8 vs. 10.9; p = 0.002; Hedges' g = -.78).
“Hypotheses testing with linear contrasts indicated that patients receiving the psycho-education intervention demonstrated lower overall severity ratings compared to the control group at the end of the intervention (7.8 vs. 10.9, p = 0.002, Hedge’s g=−.78)”
Quote in the paperSubstantial claim - Findingown data
Mean baseline symptom severity was lower in the intervention group than in the control group (10.1 vs. 12.7; p = 0.01).
“However, the mean symptom severity score at baseline was somewhat lower in the patients that received the intervention compared to the control group (10.1 ± 4.2 vs. 12.7 ± 3.8; p =0.01)”
Quote in the paperNot a substantial claim - Findingown data
For patients with average baseline QoL, control patients had higher symptom severity than intervention patients at the end of the intervention (p = .0006).
“For average levels of QoL, severity scores are higher in the control group compared to the intervention group at the end of the intervention (p=.0006) and at follow up p<.0001).”
Quote in the paperSubstantial claim - Findingown data
The main effect of time was significant only in the depression model (p = .04).
“The main effect for time was only significant in the depression model (p=.04).”
Quote in the paperNot a substantial claim - Findingown data
The intervention and control groups did not differ significantly in baseline depression symptoms (4.7 vs. 5.4; p = 0.39).
“However, there were no significant differences between the intervention group and the control group regarding the proportion of patients with depression symptoms (4.7 ± 3.5 vs. 5.4 ± 4.3; p = 0.39).”
Quote in the paperNot a substantial claim - Findingown data
After controlling for baseline QoL, the intervention had a significant main effect on total IBS-QoL (p = 0.002).
“The main effect of the intervention on total IBS-QoL was significant (p = 0.002) after controlling for baseline QoL levels (p < 0.0001).”
Quote in the paperSubstantial claim - Findingown data
Baseline QoL moderated the intervention effect on symptom severity, with a significant interaction between intervention and baseline IBS-QoL (p = 0.04).
“Baseline QOL moderated the effects of the intervention on symptom severity as evidenced by a significant interaction between the intervention and baseline levels of IBS-QoL (p = 0.04).”
Quote in the paperSubstantial claim - Findingown data
After controlling for baseline levels, the intervention significantly improved ability to change or decrease symptoms (p = 0.008).
“After controlling for baseline levels, the main effects of intervention were significantly reduced for coping skills: catastrophizing (p < 0.0001), improved ability to control symptoms (p =0.009), and improved ability to change/decrease symptoms (p = 0.008).”
Quote in the paperSubstantial claim - Findingown data
For patients with low to average baseline quality of life, intervention-related change in catastrophizing had a moderate mediation effect on GI symptom severity improvement.
“Moderated mediation analyses indicated change in anxiety, visceral sensitivity, QoL and catastrophizing due to the intervention had moderate mediation effects (Hedge’s g= −.38 to −.60) on improvements in GI symptom severity for patients entering the trial with low to average QoL.”
Quote in the paperSubstantial claim- Rests on an assumption: The mediation models' assumptions (no unmeasured confounding, correct temporal ordering, no reverse causality) hold, so that the estimated mediation effects reflect causal pathways.
- Findingown data
For patients with low to average baseline quality of life, intervention-related change in visceral sensitivity had a moderate mediation effect on GI symptom severity improvement.
“Moderated mediation analyses indicated change in anxiety, visceral sensitivity, QoL and catastrophizing due to the intervention had moderate mediation effects (Hedge’s g= −.38 to −.60) on improvements in GI symptom severity for patients entering the trial with low to average QoL.”
Quote in the paperSubstantial claim- Rests on an assumption: The mediation models' assumptions (no unmeasured confounding, correct temporal ordering, no reverse causality) hold, so that the estimated mediation effects reflect causal pathways.
- Findingown data
After controlling for baseline visceral sensitivity, the intervention had a significant main effect on VSI (p = 0.003).
“After controlling for baseline visceral sensitivity (p < 0.0001), the main effect of the psycho-education intervention on visceral sensitivity (VSI) levels was significant (p = 0.003) as was the main effect of time (p=.01).”
Quote in the paperSubstantial claim - Findingown data
The repeated measures general linear mixed effects model showed no significant intervention group by time effects.
“No significant intervention group*time effects were observed in the repeated measures general linear mixed effects model (RM GLMM).”
Quote in the paperSubstantial claim - Findingown data
After controlling for baseline levels, the intervention significantly improved ability to control symptoms (p = 0.009).
“After controlling for baseline levels, the main effects of intervention were significantly reduced for coping skills: catastrophizing (p < 0.0001), improved ability to control symptoms (p =0.009), and improved ability to change/decrease symptoms (p = 0.008).”
Quote in the paperSubstantial claim - Findingown data
Baseline quality of life was found to significantly moderate the intervention's effect on GI symptom severity.
“Mediation was examined in the context of baseline levels of QoL which was identified as a significant moderator of the effects of the intervention GI symptom severity (Figure 1, paths: f.1, f.2, g.1, g.2(46).”
Quote in the paperSubstantial claim - Findingown data
For patients with low to average baseline quality of life, intervention-related change in quality of life had a moderate mediation effect on GI symptom severity improvement.
“Moderated mediation analyses indicated change in anxiety, visceral sensitivity, QoL and catastrophizing due to the intervention had moderate mediation effects (Hedge’s g= −.38 to −.60) on improvements in GI symptom severity for patients entering the trial with low to average QoL.”
Quote in the paperSubstantial claim- Rests on an assumption: The mediation models' assumptions (no unmeasured confounding, correct temporal ordering, no reverse causality) hold, so that the estimated mediation effects reflect causal pathways.
- Findingown data
Intervention-related change in GI symptom severity had a moderate mediation effect on quality-of-life improvement, particularly for those with low to average baseline quality of life.
“Also, change in GI symptom severity due to the intervention had moderate mediation effects on improvements in QoL especially patients with low to average levels of QoL at baseline.”
Quote in the paperSubstantial claim- Rests on an assumption: The mediation models' assumptions (no unmeasured confounding, correct temporal ordering, no reverse causality) hold, so that the estimated mediation effects reflect causal pathways.
- Findingown data
Most participants reported overall IBS symptoms that were moderate to severe at baseline.
“The majority of the study sample reported overall symptoms as being moderate to severe (mild 10.3%, moderate 26.5%, severe 54.4%, very severe 8.8%)”
Quote in the paperNot a substantial claim - Findingown data
At the end of the intervention, patients receiving psycho-education showed greater improvement in coping skills to change or decrease symptoms than controls (3.0 vs. 2.1; p = 0.002; g = .77).
“Patients receiving the intervention also demonstrated improvements in their coping skills related to their ability to change/decrease symptoms at the end of the intervention compared to those in the control group (3.0 vs. 2.1, p = 0.002, g=.77)”
Quote in the paperSubstantial claim - Findingown data
Patients receiving the intervention had significant improvement in quality of life after the intervention.
“Patients in the intervention showed significant improvement on GI symptom severity, visceral sensitivity, depression, and QoL post intervention and most of these gains were maintained at 3 month follow up (Hedge’s g =−.46 to .77).”
Quote in the paperSubstantial claim- Rests on an assumption: The wait-list control condition adequately controls for non-specific effects of the intervention, so that observed improvements can be attributed to the psycho-educational intervention.
- Findingown data
The control group showed a significant reduction in visceral sensitivity.
“Even though patients receiving the intervention maintained decreased visceral sensitivity at the 3-month follow-up assessment, group differences were not maintained (37.4 vs. 32.7, p = 0.06, g=−.42) due to a significant reduction in visceral sensitivity in the control group.”
Quote in the paperSubstantial claim - Findingown data
Patients receiving the intervention had significant improvement in depression after the intervention.
“Patients in the intervention showed significant improvement on GI symptom severity, visceral sensitivity, depression, and QoL post intervention and most of these gains were maintained at 3 month follow up (Hedge’s g =−.46 to .77).”
Quote in the paperNot a substantial claim- Rests on an assumption: The wait-list control condition adequately controls for non-specific effects of the intervention, so that observed improvements can be attributed to the psycho-educational intervention.
- Findingown data
For patients with low to average baseline quality of life, intervention-related change in anxiety had a moderate mediation effect on GI symptom severity improvement.
“Moderated mediation analyses indicated change in anxiety, visceral sensitivity, QoL and catastrophizing due to the intervention had moderate mediation effects (Hedge’s g= −.38 to −.60) on improvements in GI symptom severity for patients entering the trial with low to average QoL.”
Quote in the paperSubstantial claim- Rests on an assumption: The mediation models' assumptions (no unmeasured confounding, correct temporal ordering, no reverse causality) hold, so that the estimated mediation effects reflect causal pathways.
- Findingown data
After adjustment for baseline overall symptom severity, the intervention had a significant effect on symptom severity (p = .0003).
“After controlling for baseline levels of overall symptom severity (p < 0.0001), the effect of the intervention on symptom severity was significant (p =.0003).”
Quote in the paperSubstantial claim - Findingown data
The main effect of time on symptom severity was not significant.
“The main effect for time in the model was not significant.”
Quote in the paperNot a substantial claim - Findingown data
Patients receiving the intervention had significant improvement in GI symptom severity after the intervention.
“Patients in the intervention showed significant improvement on GI symptom severity, visceral sensitivity, depression, and QoL post intervention and most of these gains were maintained at 3 month follow up (Hedge’s g =−.46 to .77).”
Quote in the paperSubstantial claim- Rests on an assumption: The wait-list control condition adequately controls for non-specific effects of the intervention, so that observed improvements can be attributed to the psycho-educational intervention.
- Findingown data
Patients receiving the intervention had significant improvement in visceral sensitivity after the intervention.
“Patients in the intervention showed significant improvement on GI symptom severity, visceral sensitivity, depression, and QoL post intervention and most of these gains were maintained at 3 month follow up (Hedge’s g =−.46 to .77).”
Quote in the paperSubstantial claim- Rests on an assumption: The wait-list control condition adequately controls for non-specific effects of the intervention, so that observed improvements can be attributed to the psycho-educational intervention.
- Findingown data
The lower depression scores in the intervention group compared with controls were maintained at follow-up (4.2 vs. 5.5; p = 0.04; g = -.50).
“and this difference was maintained at follow-up (4.2 vs. 5.5, p = 0.04, g=−.50).”
Quote in the paperNot a substantial claim - Findingown data
At the end of the intervention, patients receiving psycho-education tended to show improved coping skills to control symptoms compared with controls (3.2 vs. 2.6; p = 0.03; g = .52).
“Compared to controls, patients receiving the intervention tended to demonstrate improved coping skills to control symptoms at the end of the intervention (3.2 vs. 2.6, p = 0.03, g=.52)”
Quote in the paperSubstantial claim - Findingown data
At the end of the intervention, patients receiving psycho-education showed greater improvement in catastrophizing than controls (7.4 vs. 11.6; p = 0.001; g = -.87).
“Compared to controls, patients receiving the intervention showed improvements in catastrophizing by the end of the psycho-education intervention (7.4 vs. 11.6, p = 0.001, g=−.87)”
Quote in the paperSubstantial claim - Findingown data
After adjusting for baseline affect, the intervention did not significantly reduce anxiety (p = 0.13).
“After adjusting for baseline levels of affect (p’s <.0001), the intervention reduced depression (p = 0.006) but not anxiety (p = 0.13).”
Quote in the paperNot a substantial claim - Findingown data
At the end of the intervention, patients receiving psycho-education had higher QoL scores than controls (75.6 vs. 66.4; p = .002; g = .77).
“Patients receiving the intervention demonstrated significantly higher QoL scores than controls at the end of the intervention (75.6 vs. 66.4, p=.002, g=.77)”
Quote in the paperSubstantial claim - Findingown data
The lower symptom severity in the intervention group compared with controls was maintained at 3-month follow-up (6.8 vs. 10.2; p = 0.001; g = -.85).
“and this difference was maintained at the 3-month follow-up (6.8 vs. 10.2, p = 0.001, g=−.85).”
Quote in the paperSubstantial claim - Findingown data
The intervention group had a higher mean baseline anxiety score than the control group (9.8 vs. 7.5; p = .04).
“Compared to the control group, the intervention group had a higher mean score for anxiety (9.8 ± 3.5 vs. 7.5 ± 4.8; p =.04).”
Quote in the paperNot a substantial claim - Findingown data
Marital status differed significantly between the intervention and control groups at baseline (p = 0.04).
“but marital status differed between groups (p = 0.04)”
Quote in the paperNot a substantial claim - Findingown data
Most of these improvements persisted at the three-month follow-up.
“Patients in the intervention showed significant improvement on GI symptom severity, visceral sensitivity, depression, and QoL post intervention and most of these gains were maintained at 3 month follow up (Hedge’s g =−.46 to .77).”
Quote in the paperSubstantial claim- Rests on an assumption: The wait-list control condition adequately controls for non-specific effects of the intervention, so that observed improvements can be attributed to the psycho-educational intervention.
- Findingown data
After controlling for baseline levels, the intervention significantly reduced catastrophizing (p < 0.0001).
“After controlling for baseline levels, the main effects of intervention were significantly reduced for coping skills: catastrophizing (p < 0.0001), improved ability to control symptoms (p =0.009), and improved ability to change/decrease symptoms (p = 0.008).”
Quote in the paperSubstantial claim - Findingown data
For patients with low baseline QoL, control patients had higher symptom severity than intervention patients at follow-up (p = .0002).
“This was also observed for low levels of QOL (p=.0005, p=.0002).”
Quote in the paperSubstantial claim - Findingown data
Changes in depression by the end of the intervention showed weak to moderate evidence of mediating the intervention effect on GI symptom severity at 3-month follow-up for low, moderate, and high baseline QoL (g = -.25 to -.29).
“Changes in depression by end of the intervention showed weak to moderate evidence for mediating the effects of the intervention on GI symptom severity at 3 month follow up for low, moderate and high baseline scores of QoL (g=−.25 to −.29).”
Quote in the paperSubstantial claim - Findingown data
For patients with average baseline QoL, control patients had higher symptom severity than intervention patients at follow-up (p < .0001).
“For average levels of QoL, severity scores are higher in the control group compared to the intervention group at the end of the intervention (p=.0006) and at follow up p<.0001).”
Quote in the paperSubstantial claim - Findingown data
Changes in anxiety at the end of the intervention appeared to mediate the intervention effect on GI symptom severity at 3-month follow-up, especially for patients with low baseline QoL (g = -.54).
“Changes in anxiety at the end of intervention appeared to mediate the effects of the intervention on GI symptom severity at 3 month follow up especially for individuals with low baseline levels of QoL (g=−.54)”
Quote in the paperSubstantial claim - Findingown data
Changes in GI symptom severity after intervention mediated the intervention effect on IBS-QoL at 3-month follow-up for low (g = .65) to moderate (g = .59) baseline QoL.
“Changes in GI symptom severity post intervention mediated the effects of the psycho-education intervention on IBS-QoL at the 3-month follow up assessment for low (g=.65) to moderate (g=.59) baseline levels of QoL (Table 6).”
Quote in the paperSubstantial claim - Findingown data
Mediation by QoL was greater at low baseline IBS-QoL (g = -.60) than at moderate baseline IBS-QoL (g = -.49).
“Mediation was greatest at low (g= −.60) compared to moderate (g= −.49) baseline levels of total IBS-QoL scores.”
Quote in the paperNot a substantial claim - Findingown data
For patients with low baseline QoL, control patients had higher symptom severity than intervention patients at the end of the intervention (p = .0005).
“This was also observed for low levels of QOL (p=.0005, p=.0002).”
Quote in the paperSubstantial claim - Findingown data
For patients with moderate to low baseline IBS-QoL, the intervention effect on GI symptom severity at 3-month follow-up was mediated by change in QoL by the end of the intervention.
“The test for mediation analyses indicated that under conditions of moderate to low baseline IBS-QoL scores, the effects of the psycho-education intervention on GI symptom severity at 3 month follow up was mediated by change in QoL levels by the end of the intervention.”
Quote in the paperSubstantial claim - Study design and conductown data
Sixty-nine IBS patients were randomly assigned to either an intervention or a wait-list control.
“69 IBS patients (72% female) were randomized to an intervention or a wait-list control group.”
- Also stated in: § Subjects · plain
“Subjects were randomized to receive either the active intervention (n=34) or assigned to a wait-listed control group (n=35).”
Quote in the paperSubstantial claim- Rests on an assumption: The wait-list control condition adequately controls for non-specific effects of the intervention, so that observed improvements can be attributed to the psycho-educational intervention.
- Also stated in: § Subjects · plain
- Interpretationown data
A short psycho-educational group program is effective at altering IBS-related thoughts and fears.
“A brief psycho-educational group intervention is efficacious in changing cognitions and fears about IBS symptoms, and these changes are associated with clinically meaningful improvement in IBS symptoms and QoL.”
Quote in the paperSubstantial claim- Rests on an assumption: The mediation models' assumptions (no unmeasured confounding, correct temporal ordering, no reverse causality) hold, so that the estimated mediation effects reflect causal pathways.
- Interpretationown data
The intervention appears especially suited to patients whose baseline quality of life is low to moderate.
“The intervention seems particularly tailored to patients with low to moderate QoL baseline levels.”
Quote in the paperSubstantial claim- Rests on an assumption: The mediation models' assumptions (no unmeasured confounding, correct temporal ordering, no reverse causality) hold, so that the estimated mediation effects reflect causal pathways.
- Premisecitation
Non-pharmacologic IBS interventions have been difficult to implement due to costs, lack of trained clinicians, poor reimbursement, and preference for drugs.
“Despite the relative effectiveness of these non-pharmacologic interventions, their implementation has been hindered by factors such as added cost, unavailability of trained clinicians, inadequate reimbursement for psychosocial interventions and a general bias towards pharmacotherapy among patients and providers(29).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] source
- Interpretationown data
Such changes in thoughts and fears are linked to clinically meaningful gains in IBS symptoms and quality of life.
“A brief psycho-educational group intervention is efficacious in changing cognitions and fears about IBS symptoms, and these changes are associated with clinically meaningful improvement in IBS symptoms and QoL.”
Quote in the paperSubstantial claim- Rests on an assumption: The mediation models' assumptions (no unmeasured confounding, correct temporal ordering, no reverse causality) hold, so that the estimated mediation effects reflect causal pathways.
- Interpretationown data
A brief 5-week psycho-educational group therapy intervention can improve IBS symptoms in this patient population.
“The results demonstrate that a brief 5-week psycho-educational group therapy intervention can improve IBS symptoms in this patient population.”
Quote in the paperSubstantial claim - Interpretationown data
Baseline QoL functioned as a moderator of the intervention outcome for IBS symptoms and QoL.
“Baseline quality of life (QoL-BL) served as a predictor to the success of the intervention in decreasing IBS symptoms and in improving QoL. In other words, baseline QoL functioned as a moderator of the intervention outcome.”
Quote in the paperSubstantial claim - Study design and conductown data
There were no significant demographic differences between the intervention and control groups.
“However, there were no significant demographic differences between the groups”
Quote in the paperNot a substantial claim - Interpretationcitation
The wait-list control condition demonstrates that the positive effects of the class are not due simply to variability in IBS symptoms over time or repeated measurements.
“While not ideal, the use of a wait-list control condition in this study as in other initial studies of IBS interventions, does demonstrate the positive effects for the class are not due to simply variability in IBS symptoms over time or repeated measurements (29).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] source
- Interpretationown data
Patients with low or moderate baseline QoL showed the greatest improvement in symptom severity and QoL after intervention.
“Patients with low or moderate baseline OoL scores demonstrated the greatest improvement in symptom severity and QoL post intervention.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 13
- May combine two claims. 23
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationEducation-based interventions have been used in IBS management to increase knowledge, clarify misconceptions, teach self-management, and decrease symptom-related fears and anxiety.
“Education- based interventions have also been used as part of IBS disease management in order to increase knowledge about IBS pathophysiology, clarify misconceptions regarding what IBS is and is not, teach simple self-management strategies in areas of diet and stress management, and decrease symptom related fears and anxiety(26, 30).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [26] source
The Methods (IBS-school, page unavailable) describe teaching IBS mechanisms, correcting concerns about serious disease, and offering dietary, stress-management, and self-care advice. The Discussion reports increased perceived knowledge. The paper does not say the intervention aimed to decrease symptom-related fear or anxiety, or report that it did so. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [30] source
Classified as probably not a substantial claim. May combine two claims.
PremisecitationA critical comparison of psychological and educational treatments for IBS found evidence that cognitive, behavioral, psychodynamic, educational, and hypnotherapy-based treatments alleviated IBS symptoms, with no evidence of superiority of one over another.
“For instance, a critical comparison of various psychological and educational treatments for IBS revealed evidence from clinical trials suggesting that cognitive, behavioral, psychodynamic, educational, and hypnotherapy based treatments worked in alleviating IBS symptoms, and there was no evidence of the superiority of one treatment over the other(26, 27, 30).”
Quote in the paperSubstantial claim1 of 3 sources checkedMay combine two claims.
FindingcitationAt baseline, both the intervention and control groups had clinical levels of anxiety but not depression according to HAD cutoffs.
“As measured by the HAD, both the active treatment and the control groups displayed clinical levels of anxiety, but not depression based on the HAD cutoffs (39).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [39] source
The fMRI data analysis (p. 4) and Region of interest analysis (p. 6) concern neural responses to fearful faces, not baseline clinical symptoms. Searches for HAD cutoffs and for anxiety and depression in active-treatment and control groups found no passage addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationThe Visceral Sensitivity Index is a 15-item questionnaire with established psychometric properties.
“The Visceral Sensitivity Index (VSI) is a psychometrically well-established 15-item questionnaire designed to measure aspects of fear, anxiety, and hypervigilance that accompany misappraisals of visceral sensations and comfort(36).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [36] source
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe results are similar to those of other studies focused on patient education.
“These results are similar to those seen in other studies that focused on patient education(26, 30).”
Quote in the paperNot a substantial claim1 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSeveral modifications to traditional CBT have been evaluated and shown that CBT-based interventions can be delivered in different, more cost-effective formats.
“As a result of these limitations, several modifications to the traditional CBT format have been evaluated (e.g. patient administered, group based and Internet focused), and these studies have shown that CBT based interventions can be delivered in different, more cost effective formats(33, 46, 48).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [33] source
- cites [46] source
- cites [48] source
The Discussion reports that the CBT-based self-management program was effective with either primarily telephone or entirely in-person delivery. But it says the telephone format was not designed to be cheaper in therapist time, and calls for further research on cost-effectiveness. This source supports an alternative delivery format, not a demonstrated more cost-effective one. (LLM, conf=0.90)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataThere were no significant baseline group differences on QoL, visceral sensitivity, or coping measures.
“No significant group differences were observed at baseline for the QoL measures, VSI, or Coping Scale.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe intervention and wait-list groups did not differ significantly in sex distribution or age at baseline.
“There were no significant differences between the intervention (psycho-education intervention, N=34) and the wait-list (control, N=35) group in the distribution of sex (77% vs. 69% females) or age (46.3 ± 13.0 vs. 47.3 ± 12.3 years).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe intervention and control groups did not differ significantly in predominant bowel habits or ethnicity at baseline.
“There were no significant group differences regarding predominant bowel habits and ethnicity”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe psycho-education group tended to have higher educational levels than the control group at baseline (p = 0.08).
“and the psycho-education group tended to have somewhat higher educational levels (p = 0.08).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataChanges in VSI by the end of the intervention showed small to moderate mediation effects on GI symptom severity at 3-month follow-up, with larger effects for low baseline QoL (g = -.39).
“Changes in VSI by end of the intervention showed small moderate effects for mediating the effects of the intervention on GI symptom severity at 3 month follow up with the larger effects observed for low baseline QoL scores (g=−.39).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataChanges in catastrophizing after intervention showed a trend toward mediating the intervention effect on GI symptom severity at 3-month follow-up, with stronger mediation as baseline IBS-QoL decreased (g = -.27 to -.48).
“Changes in catastrophizing post intervention demonstrated a trend for mediating the effects of the intervention on GI symptom severity at 3 month follow up. As baseline IBS-QoL decreased from high to low, the mediating effects of changing catastrophic cognitions at 3 month follow up increased (g=−.27 to −.48).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningBlock randomization was employed: consecutive patients were assigned to the active intervention until a group was full, then a consecutive group was assigned to the wait-list.
“In order to fill classes of 8 subjects as quickly as possible, block randomization was used, e.g. consecutive subjects were assigned to the active intervention group until a complete group was obtained, and this was followed by assignment of a consecutive group of patients to the wait list group.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTreatment outcomes appear correlated with number of sessions, with one-time sessions less effective than 8-10 sessions.
“However, treatment outcomes appear to be correlated with number of sessions, with a onetime session(31, 32) being less effective as interventions with 8-10 sessions(31, 33).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
Study design and conductnone givenAppropriate tests ruled out organic disease, and an experienced gastroenterologist made the clinical IBS diagnosis.
“Organic disease was excluded with appropriate testing, and a clinical diagnosis of IBS was made by an experienced gastroenterologist.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe baseline outcome score was mean-centered and used as a covariate to adjust for pre-treatment group differences.
“In addition, the outcome measure at baseline was mean centered and included as a covariate to statistically control for any pretreatment differences between the intervention groups that may influence outcome(44).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] source
Classified as probably not a substantial claim.
Study design and conductown dataBefore enrollment, patients completed a daily symptom diary for two weeks to confirm a minimum level of symptom severity.
“Patients prospectively filled out a daily symptom diary with 6 subscales relating to severity of GI symptoms, and frequency and consistency of stool, for two weeks before entering the study to ensure a minimal symptom severity rating.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataA priori power analysis indicated that 34 participants per group were needed to detect a moderate effect size of Cohen's d = .70 with 80% power at alpha = .05.
“A priori power analysis based on a two sided independent t-test for the linear contrasts applied to test the main hypotheses indicated that at an alpha =.05, 34 cases per group were required to detect a moderate effect size (Cohen’s d = .70) with adequate power (1-Beta = .80).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe intervention helped patients reduce depression symptoms and visceral anxiety.
“In addition, the intervention helped patients to reduce symptoms of depression (g= −.50) and visceral anxiety (g=−.84).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningThe psycho-educational group intervention would benefit patients and clinicians by reducing treatment cost and unnecessary follow-up visits and by enhancing self-management and coping.
“Like other recently proposed novel delivery methods of cognitive behavioral approaches, the psycho-educational group intervention would be beneficial to patients and clinicians, by reducing the cost of treatment, the amount of unnecessary follow up visits to clinicians, and enhance the patients ability to self-manage and cope with the symptoms of their condition.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe intervention gave patients tools to control symptoms and improve catastrophizing, both maintained at 3-month follow-up.
“The intervention also gave patients tools to control their symptoms (g=.52)and improve catastrophizing (g=−.87) both of which were maintained at the 3-month follow up assessment.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenAll analyses controlled for baseline differences in clinical variables.
“and all analyses were performed controlling for baseline differences in clinical variables.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataA brief CBT group psycho-educational model is an efficient, efficacious, and clinically useful treatment that can reduce symptoms and improve quality of life.
“The present study suggests that a brief CBT group psycho-educational model is an efficient, efficacious, and clinically useful treatment that can provide symptom reduction, and improvement in quality of life of patients.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataLike Lackner et al. (2010), this study demonstrated reduced IBS symptoms and improved coping with a short 5-week group-based CBT and relaxation psycho-education intervention despite limited direct physician contact hours.
“Similar to the Lackner et al (2010)(33) study we were also able to demonstrate reduced IBS symptoms and improved coping using a short 5 week group based CBT and relaxation psycho-education intervention, despite the fact that patients had limited number of direct contact hours with a physician.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] source
May combine two claims.
Interpretationown dataCompared with wait-list controls, treated patients had significant reductions in IBS symptom severity and improvements in QoL, many maintained at 3 months.
“Compared to a wait-list control, patients undergoing the treatment reported overall significant reduction in IBS symptom severity and significant improvement in health related quality of life (QoL), and many of the improvements were maintained at 3 months follow up.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductreasoningBlock randomization was used, which resulted in some baseline differences in symptom severity and anxiety between groups.
“Due to the nature of organizing a group therapy class, block randomization was used to assign participants to the intervention and control groups in this study, resulting in some baseline differences in symptom severity and anxiety”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe between-group effect sizes on IBS-QoL were larger than those reported in other cognitive behavioral and mindfulness approaches, suggesting the findings are clinically meaningful.
“The effect size differences between groups on IBS-QOL (hedge’s g=−.78 at post intervention, −.87 at three month follow up) are larger than the small (Cohen’s d=.20) to moderate (Cohen’s d=.57) effect sizes reported in other cognitive behavioral and mindfulness approaches, (27, 29, 51) and suggest that the observed findings are clinically meaningful.”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
Interpretationnone givenThe study demonstrates the feasibility of a cost-effective brief group psycho-educational therapy intervention whose cost equaled a one-hour gastroenterologist consultation.
“This study demonstrates the feasibility of a cost-effective brief group psycho-educational therapy intervention that equaled the cost of one-hour consultation with a gastroenterologist.”
Quote in the paperSubstantial claim- Rests on an assumption: The cost of the psycho-education group intervention equals the cost of a one-hour consultation with a gastroenterologist.
May combine two claims.
Interpretationown dataPatients attending the psycho-education classes improved on all key measures by the end of the intervention and had lower overall symptom severity than controls.
“Patients attending the psycho-education classes improved on all key measures by the end of the intervention, and demonstrated lower overall symptom severity ratings than those in the control group.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataBecause the results came from a relatively small sample, they need replication in a larger randomized controlled trial before a final conclusion about efficacy can be made.
“As the results were obtained in a relatively small sample of patients, our findings need replication in a larger randomized controlled trial before a final conclusion can be made regarding the efficacy of this form of intervention.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataImprovements in IBS-QoL by the end of intervention mediated improvements in GI symptom severity at 3-month follow-up for patients with low to moderate baseline IBS-QoL, suggesting an alternative intervention may be more helpful for those with higher baseline QoL.
“Similarly, improvements in IBS-QoL by the end of the intervention mediated improvements in overall GI symptom severity at 3 month follow up in individuals with low to moderate baseline values of IBS QoL, suggesting that an alternative intervention may be more helpful for individuals with higher QoL baseline levels.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The wait-list control condition adequately controls for non-specific effects of the intervention, so that observed improvements can be attributed to the psycho-educational intervention.
“Subjects were randomized to receive either the active intervention (n=34) or assigned to a wait-listed control group (n=35).”
The paper relies on this without support.
The mediation models' assumptions (no unmeasured confounding, correct temporal ordering, no reverse causality) hold, so that the estimated mediation effects reflect causal pathways.
“Simultaneous regression analysis was applied to test prospective (time-lagged) mediation models to identify potential mechanisms underlying the class intervention effects (45).”
The paper relies on this without support.
Group psycho-educational interventions are not commonly available for IBS patients.
“although group psycho-educational interventions appear to be a helpful adjunct to standard medical care they are not commonly available for IBS patients.”
The paper relies on this without support.
The limited availability of group psycho-educational interventions for IBS is due to lack of trained clinicians, added cost, inadequate reimbursement, and a bias towards pharmacotherapy.
“This is likely a result of several factors including lack of availability of appropriately trained clinicians, added cost and inadequate reimbursement for psychosocial interventions, and”
The paper relies on this without support.
The cost of the psycho-education group intervention equals the cost of a one-hour consultation with a gastroenterologist.
“This study demonstrates the feasibility of a cost-effective brief group psycho-educational therapy intervention that equaled the cost of one-hour consultation with a gastroenterologist.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
QoL effect size at follow-up differs between Results and Discussion
MinorThe Results section reports the 3-month QoL effect size as g=.62, while the Discussion states it was −.87 at three months. The same outcome and time point cannot have both values.
“Patients receiving the intervention demonstrated significantly higher QoL scores than controls at the end of the intervention (75.6 vs. 66.4, p=.002, g=.77) and at the 3-month follow-up (77.6 vs. 70.2, p=.012, g=.62).”
“The effect size differences between groups on IBS-QOL (hedge’s g=−.78 at post intervention, −.87 at three month follow up) are larger than the small (Cohen’s d=.20) to moderate (Cohen’s d=.57) effect sizes reported in other cognitive behavioral and mindfulness approaches, (27, 29, 51) and suggest that the observed findings are clinically meaningful.”
Limitations overlook a significant demographic difference
MinorThe limitations state that there were no significant demographic differences, but the results report a significant between-group difference in marital status (p = 0.04).
“However, there were no significant demographic differences between the groups, and all analyses were performed controlling for baseline differences in clinical variables.”
“There were no significant group differences regarding predominant bowel habits and ethnicity, but marital status differed between groups (p = 0.04), and the psycho-education group tended to have somewhat higher educational levels (p = 0.08).”
Abstract effect-size range excludes a reported post-intervention result
MinorThe abstract's stated effect-size range starts at −.46, but the results report a post-intervention visceral-sensitivity effect size of −.84 for one of the outcomes summarized there.
“Patients in the intervention showed significant improvement on GI symptom severity, visceral sensitivity, depression, and QoL post intervention and most of these gains were maintained at 3 month follow up (Hedge’s g =−.46 to .77).”
“Patients receiving the intervention demonstrated significantly less visceral sensitivity than controls at end of the class (34.0 vs. 42.3, p = 0.001, g=−.84).”
Discussion reports different quality-of-life effect sizes
MinorThe discussion gives negative IBS-QoL effect sizes of −.78 and −.87, while the results report positive values of .77 and .62 at the same two assessments. The discrepancy changes both the direction and the reported magnitude of a conclusion-bearing result.
“The effect size differences between groups on IBS-QOL (hedge’s g=−.78 at post intervention, −.87 at three month follow up)”
“Patients receiving the intervention demonstrated significantly higher QoL scores than controls at the end of the intervention (75.6 vs. 66.4, p=.002, g=.77) and at the 3-month follow-up (77.6 vs. 70.2, p=.012, g=.62).”
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139 · see citing works
Addressing Moderated Mediation Hypotheses: Theory, Methods, and Prescriptions
Preacher, K. J., Rucker, D. D., & Hayes, A. F. (2007) · Multivariate Behavioral Research · doi:10.1080/00273170701341316 · Cited by 9,973 · see citing works
Beyond Baron and Kenny: Statistical Mediation Analysis in the New Millennium
Hayes, A. F. (2009) · Communication Monographs · doi:10.1080/03637750903310360 · Cited by 9,757 · see citing works
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440 · see citing works
Rosenstiel, A. K., & Keefe, F. J. (1983) · Pain · doi:10.1016/0304-3959(83)90125-2 · Cited by 2,314 · see citing works
McFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872 · see citing works
The impact of irritable bowel syndrome on health-related quality of life
Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B., & Mayer, E. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.16484 · Cited by 781 · see citing works
Self-citationAn Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome
American College of Gastroenterology IBS Task Force (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.122 · Cited by 694 · see citing works
(2011) · Springer eBooks · doi:10.1007/springerreference_44317 · Cited by 549 · see citing works
The brain-gut axis in abdominal pain syndromes.
Mayer, E. A., & Tillisch, K. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-012309-103958 · Cited by 511 · see citing works
Self-citationLabus, J. S., Bolus, R., Chang, L., Wiklund, I., Naesdal, J., Mayer, E. A., & Naliboff, B. D. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02007.x · Cited by 475 · see citing works
Self-citationAn irritable bowel syndrome-specific symptom questionnaire: development and validation
K., W. I., S., F., J., H. C., H., J. R., F., L. G., A., M. E., A., P. R., K., W. I., & J., N. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310004209 · Cited by 324 · see citing works
Craske, M. G., Wolitzky-Taylor, K. B., Labus, J., Wu, S., Frese, M., Mayer, E. A., & Naliboff, B. D. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.04.001 · Cited by 243 · see citing works
Self-citationMayer, E. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0801447 · Cited by 243 · see citing works
Self-citationLjótsson, B., Hedman, E., Andersson, E., Hesser, H., Lindfors, P., Hursti, T., Rydh, S., Rück, C., Lindefors, N., & Andersson, G. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.139 · Cited by 218 · see citing works
Clinical Determinants of Health-Related Quality of Life in Patients With Irritable Bowel Syndrome
Spiegel, B. M. R., Gralnek, I. M., Bolus, R. R., Chang, L., Dulai, G. S., Mayer, E. A., & Naliboff, B. D. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.16.1773 · Cited by 198 · see citing works
Self-citationReview article: probiotics and prebiotics in irritable bowel syndrome
SPILLER, R. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03750.x · Cited by 190 · see citing works
Moss-Morris, R., McAlpine, L., Didsbury, L. P., & Spence, M. J. (2010) · Psychological Medicine · doi:10.1017/s0033291709990195 · Cited by 187 · see citing works
Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome
Hahn, B. A., Kirchdoerfer, L. J., Fullerton, S. C., & Mayer, E. A. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00168.x · Cited by 186 · see citing works
Self-citationTein, J.-Y., Sandler, I. N., MacKinnon, D. P., & Wolchik, S. A. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.4.617 · Cited by 186 · see citing works
Lackner, J. M., Jaccard, J., Krasner, S. S., Katz, L. A., Gudleski, G. D., & Holroyd, K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.03.004 · Cited by 176 · see citing works
Heymann-Monnikes, I., Arnold, R., Florin, I., Herda, C., Melfsen, S., & Monnikes, H. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01937.x · Cited by 169 · see citing works
Sleep Disturbances in Clinic Patients With Functional Bowel Disorders
Fass, R., Fullerton, S., Tung, S., & Mayer, E. A. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02009.x · Cited by 163 · see citing works
Self-citationSex specific alterations in autonomic function among patients with irritable bowel syndrome
Tillisch, K., Mayer, E. A., Labus, J. S., Stains, J., Chang, L., & Naliboff, B. D. (2005) · Gut · doi:10.1136/gut.2004.058685 · Cited by 156 · see citing works
Self-citationHypnotherapy for treatment of irritable bowel syndrome
Webb, A. N., Kukuruzovic, R., Catto-Smith, A. G., & Sawyer, S. M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005110.pub2 · Cited by 147 · see citing works
Bijkerk, C. J., de Wit, N. J., Muris, J. W. M., Jones, R. H., Knottnerus, J. A., & Hoes, A. W. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07158.x · Cited by 131 · see citing works
Hansen, W. B., & McNeal, R. B. (1996) · Health Education Research · doi:10.1093/her/11.4.501 · Cited by 126 · see citing works
Self-management for women with irritable bowel syndrome
Heitkemper, M. M., Jarrett, M. E., Levy, R. L., Cain, K. C., Burr, R. L., Feld, A., Barney, P., & Weisman, P. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00242-3 · Cited by 119 · see citing works
Jarrett, M. E., Cain, K. C., Burr, R. L., Hertig, V. L., Rosen, S. N., & Heitkemper, M. M. (2009) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.479 · Cited by 89 · see citing works
Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome
Chey, W. D., Maneerattaporn, M., & Saad, R. (2011) · Gut and Liver · doi:10.5009/gnl.2011.5.3.253 · Cited by 89 · see citing works
Complementary and alternative medicine for treatment of irritable bowel syndrome.
(2009) · PubMed Central · Cited by 89 · see citing works
Ringström, G., Störsrud, S., Posserud, I., Lundqvist, S., Westman, B., & Simrén, M. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283333b61 · Cited by 85 · see citing works
Self-citationEffects of multidisciplinary education on outcomes in patients with irritable bowel syndrome
Saito, Y. A., Prather, C. M., Van Dyke, C. T., Fett, S., Zinsmeister, A. R., & Locke, G. R. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00241-1 · Cited by 77 · see citing works
Lackner, J. M., Gudleski, G. D., Keefer, L., Krasner, S. S., Powell, C., & Katz, L. A. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.02.007 · Cited by 76 · see citing works
Holroyd, K. A., Labus, J. S., & Carlson, B. (2009) · Pain · doi:10.1016/j.pain.2009.02.019 · Cited by 61 · see citing works
Self-citationTillisch, K., Labus, J., Nam, B., Bueller, J., Smith, S., Suyenobu, B., Siffert, J., McKelvy, J., Naliboff, B., & Mayer, E. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04958.x · Cited by 60 · see citing works
Self-citationMindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial
Gaylord, S. A., Whitehead, W. E., Coble, R. S., Faurot, K. R., Palsson, O. S., Garland, E. L., Frey, W., & Mann, J. D. (2009) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-9-24 · Cited by 53 · see citing works
Management of Irritable Bowel Syndrome
TORII, A., & TODA, G. (2004) · Internal Medicine · doi:10.2169/internalmedicine.43.353 · Cited by 49 · see citing works
Culture, gaze and the neural processing of fear expressions
Adams, R. B., Franklin, R. G., Rule, N. O., Freeman, J. B., Kveraga, K., Hadjikhani, N., Yoshikawa, S., & Ambady, N. (2010) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsp047 · Cited by 47 · see citing works
Behavioral and Complementary Approaches for the Treatment of Irritable Bowel Syndrome
Wald, A., & Rakel, D. (2008) · Nutrition in Clinical Practice · doi:10.1177/0884533608318677 · Cited by 46 · see citing works
Ringström, G., Störsrud, S., Lundqvist, S., Westman, B., & Simrén, M. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-10 · Cited by 37 · see citing works
Self-citationHutchings, H. A., Wareham, K., Baxter, J. N., Atherton, P., Kingham, J. G. C., Duane, P., Thomas, L., Thomas, M., Ch'ng, C. L., & Williams, J. G. (2011) · ISRN Gastroenterology · doi:10.5402/2011/206103 · Cited by 37 · see citing works
Koloski, N. A., Boyce, P. M., Jones, M. P., & Talley, N. J. (2012) · Quality of Life Research · doi:10.1007/s11136-011-9985-5 · Cited by 30 · see citing works
Cognitive-Behavioral Hypnotherapy in the Treatment of Irritable-Bowel-Syndrome-Induced Agoraphobia
Golden, W. L. (2007) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207140601177889 · Cited by 24 · see citing works
Hypnotherapeutische Interventionen beim Reizdarmsyndrom – eine systematische Übersicht
Hefner, J., Rilk, A., Herbert, B., Zipfel, S., Enck, P., & Martens, U. (2009) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0028-1109697 · Cited by 23 · see citing works
Recent developments in the therapy of irritable bowel syndrome
Saad, R. J., & Chey, W. D. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.117 · Cited by 21 · see citing works
The Placebo Response Rate in Irritable Bowel Syndrome and Inflammatory Bowel Disease
Sands, B. E. (2009) · Digestive Diseases · doi:10.1159/000268123 · Cited by 17 · see citing works
Clavé, P. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01808.x · Cited by 12 · see citing works
[Progressive muscle relaxation according to E. Jacobson. A modern relaxation technique].
Kohl, F. (2002) · PubMed · Cited by 10 · see citing works
Whorwell, P. J. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1361 · Cited by 8 · see citing works
Flagged first, then by citations
1 of the 51 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Lackner JM, 2009, Cognitive‐Behavioral Treatment of Functional Pain Disorders. Functional Pain Syndromes: Presentation and Pathophysiology, 491
- Salt WB, 1997, IBS and the Mind‐Body Brain‐Gut Connection
Cited by
Sorted by citations
Brain–gut–microbiome interactions in obesity and food addiction
Gupta, A., Osadchiy, V., & Mayer, E. A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0341-5 · Cited by 268 · see citing works
Self-citationLaird, K. T., Tanner-Smith, E., Russell, A. C., Hollon, S., & Walker, L. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.11.001 · Cited by 140 · see citing works
Laird, K. T., Tanner-Smith, E. E., Russell, A. C., Hollon, S. D., & Walker, L. S. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.11.020 · Cited by 135 · see citing works
Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice
Moayyedi, P., Mearin, F., Azpiroz, F., Andresen, V., Barbara, G., Corsetti, M., Emmanuel, A., Hungin, A. P. S., Layer, P., Stanghellini, V., et al. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617731968 · Cited by 135 · see citing works
The Place of Stress and Emotions in the Irritable Bowel Syndrome
Sonia Pellissier, A., & Bonaz, B. L. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.09.005 · Cited by 97 · see citing works
Labus, J. S., Hubbard, C. S., Bueller, J. A., Ebrat, B., Tillisch, K., Chen, M., Stains, J., Dukes, G. E., Kelleher, D. L., Naliboff, B. D., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.016 · Cited by 90 · see citing works
Self-citationKuo, B., Bhasin, M., Jacquart, J., Scult, M. A., Slipp, L. E., Riklin, E. I. K., Lepoutre, V., Comosa, N., Norton, B.-A., Dassatti, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123861 · Cited by 85 · see citing works
Sex-Related Differences of Cortical Thickness in Patients with Chronic Abdominal Pain
Jiang, Z., Dinov, I. D., Labus, J. S., Shi, Y., Zamanyan, A., Gupta, A., Ashe-McNalley, C., Hong, J., Tillisch, K., Toga, A. W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073932 · Cited by 81 · see citing works
Self-citationLayer, P., Andresen, V., Allescher, H. ‐., Bischoff, S. C., Claßen, M., Elsenbruch, S., Freitag, M., Frieling, T., Gebhard, M., Goebel‐Stengel, M., et al. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1591-4794 · Cited by 78 · see citing works
Health-Related Quality of Life in Irritable Bowel Syndrome
Cassar, G. E., Youssef, G., Knowles, S., Moulding, R., & Austin, D. (2020) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000530 · Cited by 27 · see citing works
Windgassen, S., Moss‐Morris, R., Chilcot, J., Sibelli, A., Goldsmith, K., & Chalder, T. (2017) · British Journal of Health Psychology · doi:10.1111/bjhp.12250 · Cited by 67 · see citing works
Irritable Bowel Syndrome: Patient-Provider Interaction and Patient Education
Halpert, A. D. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7010003 · Cited by 62 · see citing works
Mind-body treatments of irritable bowel syndrome symptoms: An updated meta-analysis
Shah, K., Ramos-Garcia, M., Bhavsar, J., & Lehrer, P. M. (2019) · Behaviour Research and Therapy · doi:10.1016/j.brat.2019.103462 · Cited by 55 · see citing works
Efficacy and safety of enteric coated capsules of anise oil to treat irritable bowel syndrome
Mosaffa-Jahromi, M., Lankarani, K. B., Pasalar, M., Afsharypuor, S., & Tamaddon, A. M. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.10.083 · Cited by 55 · see citing works
Epigenetic Mechanisms of Integrative Medicine
Kanherkar, R. R., Stair, S. E., Bhatia-Dey, N., Mills, P., Chopra, D., & Csoka, A. (2017) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2017/4365429 · Cited by 48 · see citing works
Treatment of abdominal pain in irritable bowel syndrome
Vanuytsel, T., Tack, J. F., & Boeckxstaens, G. E. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0966-7 · Cited by 51 · see citing works
Windgassen, S., Moss-Morris, R., Goldsmith, K., & Chalder, T. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2018.11.013 · Cited by 33 · see citing works
Altayar, O., Sharma, V., Prokop, L. J., Sood, A., & Murad, M. H. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/549308 · Cited by 47 · see citing works
Cognitive-behavioral therapy for the management of irritable bowel syndrome
Tang, Q.-L. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i46.8605 · Cited by 37 · see citing works
Cong, X. S., Perry, M., Bernier, K. M., Young, E. E., & Starkweather, A. R. (2017) · Western Journal of Nursing Research · doi:10.1177/0193945917727705 · Cited by 33 · see citing works
Cao, B., Wang, J., Mu, L., Poon, D. C.-H., & Li, Y. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.09.010 · Cited by 35 · see citing works
Psychotherapeutic Interventions in Irritable Bowel Syndrome
Hetterich, L., & Stengel, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00286 · Cited by 37 · see citing works
Jang, A., Hwang, S.-K., Padhye, N. S., & Meininger, J. C. (2017) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm17017 · Cited by 35 · see citing works
Irritable bowel syndrome: an integrated explanatory model for clinical practice
Hungin, A. P. S., Becher, A., Cayley, B., Heidelbaugh, J. J., Muris, J. W. M., Rubin, G. P., Seifert, B., Russell, A., & de Wit, N. J. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12524 · Cited by 31 · see citing works
Magharei, M., Jaafari, S., Mansouri, P., Safarpour, A. R., & Taghavi, S. A. (2019) · Europe PMC (PubMed Central) · doi:10.30476/ijcbnm.2019.40844 · Cited by 29 · see citing works
Hu, S., Sun, Q., Du, W., Song, J., Li, X., Zhang, P., Xu, J., & Xu, G. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00575-7 · Cited by 25 · see citing works
Risk of Pancreatitis Following Treatment of Irritable Bowel Syndrome With Eluxadoline
Gawron, A., & Bielefeldt, K. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.08.006 · Cited by 26 · see citing works
Personalisation of therapy in irritable bowel syndrome: a hypothesis.
Black, C., & Ford, A. C. (2024) · The Lancet Gastroenterology and Hepatology · doi:10.1016/s2468-1253(24)00245-0 · Cited by 23 · see citing works
Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety
Lan, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11422 · Cited by 24 · see citing works
Irritable Bowel Syndrome: News from an Old Disorder
Ferreira, A. I., Garrido, M., & Castro-Poças, F. (2019) · GE: Portuguese Journal of Gastroenterology · doi:10.1159/000503757 · Cited by 23 · see citing works
Thakur, E. R., Khasawneh, M., Moayyedi, P., Black, C. J., & Ford, A. C. (2025) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(25)00238-9 · Cited by 24 · see citing works
Altered attentional control linked to catastrophizing in patients with irritable bowel syndrome
Henrich, J. F., & Martin, M. (2018) · British Journal of Health Psychology · doi:10.1111/bjhp.12307 · Cited by 18 · see citing works
Du, W., Hu, S., Li, X., Zhang, P., Jiang, X., Yu, S.-P., & Xu, G. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0318-3 · Cited by 18 · see citing works
Belgian consensus on irritable bowel syndrome
Kindt, S., Louis, H., Schepper, H. U. D., Arts, J., Caenepeel, P., Looze, D. A. D., Gerkens, A., Holvoet, T., Latour, P., Mahler, T., et al. (2022) · Acta gastro-enterologica belgica · doi:10.51821/85.2.10100 · Cited by 18 · see citing works
Sarter, L., Heider, J., Witthöft, M., Rief, W., & Kleinstäuber, M. (2022) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2022.03.001 · Cited by 17 · see citing works
Lindfors, P., Axelsson, E., Engstrand, K., Störsrud, S., Jerlstad, P., Törnblom, H., Ljótsson, B., Simrén, M., & Ringström, G. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.005 · Cited by 14 · see citing works
Self-citationDie Rolle Der Psychotherapie Beim Reizdarmsyndrom
Weibert, E., & Stengel, A. (2019) · PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie · doi:10.1055/a-0829-6990 · Cited by 11 · see citing works
Tayama, J., Saigo, T., Ogawa, S., Takeoka, A., Hamaguchi, T., Inoue, K., Okamura, H., Yajima, J., Matsudaira, K., Fukudo, S., et al. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13402 · Cited by 11 · see citing works
Development and Validation of the Gastrointestinal Unhelpful Thinking Scale (GUTs)
Knowles, S. R., Apputhurai, P., Burgell, R., & Keefer, L. (2022) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000644 · Cited by 12 · see citing works
Sun, Q., Weng, R., Li, J., Li, Y., Xu, J., Li, R., Lu, X., & Xu, G. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00029.2023 · Cited by 10 · see citing works
Prevalence and Factors related to Irritable Bowel Syndrome in University Students
Park, J., Jung, Y.-M., Lee, H. J., & Seo, J.-Y. (2018) · Journal of Korean Academy of Fundamentals of Nursing · doi:10.7739/jkafn.2018.25.4.282 · Cited by 8 · see citing works
Editorial: Pediatric Functional Gastrointestinal Disorders: Challenges in Diagnosis and Treatment
Vernon‐Roberts, A., Safe, M., & Day, A. S. (2024) · Gastrointestinal Disorders · doi:10.3390/gidisord6010021 · Cited by 10 · see citing works
Kamp, K., Plantinga, A., Cain, K. C., Burr, R. L., Barney, P., Jarrett, M. E., Luna, R. A., Savidge, T., Shulman, R. J., & Heitkemper, M. M. (2021) · Biological Research For Nursing · doi:10.1177/1099800420984543 · Cited by 5 · see citing works
A Meta-Analysis on the Effects of Mind-Body Therapy on Patients with Irritable Bowel Syndrome
Choi, E. H., Kim, M. J., & Lee, E. N. (2020) · Journal of Korean Academy of Nursing · doi:10.4040/jkan.19224 · Cited by 5 · see citing works
Using Telehealth to Train Providers of a Cancer Support Intervention
Brandon, A. R., Song, L., Deal, A. M., Gellin, M., Sherwood, E., Bloom, D. L., Doernberg, A., Manning, M. L., Young, M. D., & Rosenstein, D. L. (2015) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2014.0208 · Cited by 4 · see citing works
Lackner, J. M., Quigley, B. M., Zilcha‐Mano, S., Radziwon, C. D., Krasner, S. S., Gudleski, G. D., & Enck, P. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.10.003 · Cited by 3 · see citing works
Arslan, E., & Kıyak, E. (2025) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000879 · Cited by 2 · see citing works
Patel, R. M., & Wong, D. J. (2024) · Internal Medicine Journal · doi:10.1111/imj.16586 · Cited by 2 · see citing works
Löfgren, E., Lindfors, P., Nilsson, K., Wannstedt, J., Bonnert, M., & Uusijärvi, A. (2023) · Gastrointestinal Disorders · doi:10.3390/gidisord6010001 · Cited by 2 · see citing works
Tejedor, M., Rodríguez‐Alcalde, D., Cruces, C., Hernando, E., López-Martín, M. C., Briz, R., Calvache, A., Barranco, R., Castillo, L. A., Chico, I., et al. (2020) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2020.7276/2020 · Cited by 2 · see citing works
Commentary: psychoeducation in the irritable bowel syndrome ‐ talking the talk
Quigley, E. M. M. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12220 · Cited by 2 · see citing works
Validation of the menstrual sensitivity index in adolescents
Seidman, L. C., Handy, A. B., & Payne, L. A. (2025) · PAIN Reports · doi:10.1097/pr9.0000000000001315 · Cited by 1 · see citing works
Barandouzi, Z. A., Chen, J., Henderson, W. A., Starkweather, A. R., & Cong, X. S. (2024) · Interdisciplinary Nursing Research · doi:10.1097/nr9.0000000000000069 · Cited by 1 · see citing works
Pain in irritable bowel syndrome
Zielińska, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821324-7.00010-1 · Cited by 1 · see citing works
Irritable Bowel Syndrome: The effect of FODMAPs and meditation on pain management
Cearley, S. M., Immaneni, S., & Shankar, P. (2017) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2017.05.003 · Cited by 1 · see citing works
Paik, B., Sarker, S., Chowdhury, P., & Ahmed, M. (2015) · Mediscope · doi:10.3329/mediscope.v2i2.25406 · Cited by 1 · see citing works
The Gut-Brain Axis—From Science to Clinical Practice
Quigley, E. M. M. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.100975
Podcasts zur Psychoedukation bei Reizdarmsyndrom: Eine Mixed-methods-Analyse
Gerhold, P., Löwe, B., Huber, S., & Weigel, A. (2025) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2550-9549
Tayama, J., Hamaguchi, T., Koizumi, K., Yamamura, R., Okubo, R., Kawahara, J., Inoue, K., Takeoka, A., Schneider, A., & Fukudo, S. (2022) · medRxiv · doi:10.1101/2022.12.22.22283873
A INFLUÊNCIA PSICOSSOMÁTICA EM PORTADORES DA SÍNDROME DO INTESTINO IRRITÁVEL
Duque, G. M., Pecemilis, I. S., Vargas, B. C. S., & Almeida, L. B. P. D. (2021) · Revista Científica da Faculdade de Medicina de Campos · doi:10.29184/1980-7813.rcfmc.350.vol.16.n2.2021 · Cited by 1 · see citing works
A systematic review outlining the impact of education on patients and physicians in gastroenterology
Georghiades, A., & Eiroá‐Orosa, F. J. (2021) · Psychology Health & Medicine · doi:10.1080/13548506.2021.1890158
Irritable Bowel Syndrome : Studies of central pathophysiological mechanisms and effects of treatment
Lowén, M. (2015) · Linköping University medical dissertations · doi:10.3384/diss.diva-122144
Meditation for Major Depressive Disorder: A Systematic Review
Sorbero, M. E. S., Ahluwalia, S. C., Reynolds, K. A., Lovejoy, S. L., Farris, C. A., Sloan, J., Miles, J. N. V., Vaughan, C., Kandrack, R., Apaydin, E. A., et al. (2015) · RAND Corporation eBooks · doi:10.7249/rr1138
ПСихологичеСкие оСобенноСти Пациентов С ф Ункциональными и воСПалительными заболеваниЯми киШечника
Razumovsky, V. I. (2014) · CyberLeninK (CyberLeninka)
10.1016/b978-84-9113-949-2.00122-0
(2000) · Time to knit · doi:10.1016/b978-84-9113-949-2.00122-0
- Authors
- Labus, J., Gupta, A., Gill, H. K., Posserud, I., Mayer, M., Raeen, H., Bolus, R., Simren, M., Naliboff, B. D., & Mayer, E. A.
- Affiliations
- University of California, Los Angeles (US)
- Columbia University (US)
- Sahlgrenska University Hospital (SE)
- Department of Internal Medicine Sahlgrenska University Hospital Göteborg Sweden
- Corresponding author
- Mayer, E. A.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2012-12-03
- Volume
- 37
- Issue
- 3
- Pages
- 304-315
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- PMC
- PMC3829380
- OpenAlex
- W2066705619
- Semantic Scholar
- 48c64076138358a588a61e44dcf9f40a4873758f
- Cited by
- 64
- References
- 51
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 8 · 2019: 4 · 2018: 6 · 2017: 7 · 2016: 4 · 2015: 8 · 2014: 3 · 2013: 4
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Alimentary Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- GlaxoSmithKline
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (P50DK064539)
- National Center for Complementary and Integrative Health (R24AT002681)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Health Professions › Pharmacy › Infant Health and Development
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Keywords
- irritable bowel syndrome, psychoeducational intervention, group intervention, cognitive behavioral therapy, visceral sensitivity, gastrointestinal symptoms, quality of life, depression, anxiety, catastrophizing, self-efficacy, relaxation techniques, mediation analysis
- MeSH terms
- Adult, Female, Humans, Male, Middle Aged, Patient Education as Topic, Psychotherapy, Group, Quality of Life, Severity of Illness Index, Waiting Lists, Treatment Outcome, Meditation, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review